Synthesis and Application Evaluation of the Novel Nanocluster MnS@Tf for Tumor Management.

Ziyi Yang, Bingxin Gu, Xinyue Du, Bin Zhu, Fengsheng Zhang, Qiwei Tian, Shaoli Song

Abstract read

In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ziyi YangDepartment of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai 200032, China.

Bingxin GuDepartment of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai 200032, China.

Xinyue DuDepartment of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai 200032, China.

Bin ZhuDepartment of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai 200032, China.

Fengsheng ZhangDepartment of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai 200032, China.

Qiwei TianShanghai University of Medicine and Health Sciences, Shanghai 201318, China.ORCID 0000-0002-4709-7378

Shaoli SongDepartment of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai 200032, China.ORCID 0000-0003-2544-7522

Funding

National Natural Science Foundation of China 82272035National Natural Science Foundation of China U23A20465

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemodynamic therapydual-modal imaginggas therapyH2SMnStransferrin receptor

Identifiers

PMID41755017

DOI10.3390/pharmaceutics18020276

PMCPMC12944535

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.